Latest Biotech News

Amgen reported compelling new data from a clinical trial demonstrating its cholesterol-lowering injection Repatha’s ability to reduce the risk of a composite endpoint including heart disease...

Cartography Biosciences, a biotech developing T-cell engaging bispecific and multispecific antibody therapeutics for cancer, closed a $67 million Series B financing led by Pfizer Ventures. The...

Pharmaceutical companies including Abbvie, Johnson & Johnson, Bristol Myers Squibb, Takeda, and Astex have collaborated through the AI Structural Biology network to share proprietary...

Researchers at the La Jolla Institute for Immunology and Columbia University Irving Medical Center have uncovered compelling evidence suggesting that amyotrophic lateral sclerosis (ALS) may be...

Matthew Padula and collaborators have utilized Deep Visual Proteomics (DVP), combining imaging, laser isolation, and high-resolution mass spectrometry, to generate a spatial map of a rare bladder...

Several biotech companies face regulatory challenges as the FDA and authorities grapple with resource limitations amid a government funding lapse. Fortress Biotech received a Complete Response...

Memorial Sloan Kettering Cancer Center presented multiple groundbreaking radiation therapy studies at the 2025 ASTRO meeting, highlighting novel approaches to improve treatment efficacy across...

Danish biotech Genmab completed an $8 billion all-cash purchase of clinical-stage Merus, marking its largest acquisition and a strategic pivot toward an integrated biotech model. The deal centers...

Researchers at the University of British Columbia (UBC) achieved a historic first by transplanting a kidney converted from blood type A to universal blood type O using specialized enzymes...

Scientists from McMaster University and Massachusetts Institute of Technology have utilized artificial intelligence to discover and predict the mechanism of action of enterololin, a novel...

Takeda Pharmaceutical Company announced its complete withdrawal from cell therapy research and development, marking a strategic portfolio reprioritization. The company is seeking external...

European life sciences investment firm Asabys Partners has integrated Aliath Bioventures, formerly Alta Life Sciences, in a deal that expands Asabys assets under management from $351 million to...

A team from Chan Zuckerberg Biohub, led by mass spectrometry expert Josh Elias, developed a novel mass spectrometry-based method to map protein subcellular localization changes, notably during...

Jane Goodall, internationally renowned primatologist and conservationist, has died at age 91. Best known for her pioneering work at Tanzania’s Gombe National Park, she transformed primatology by...

Researchers at the Spanish National Cancer Research Centre (CNIO), led by Felipe Cortés-Ledesma and Ernesto López de Alba, have comprehensively catalogued approximately 20,000 distinct DNA scar...

La Jolla Institute for Immunology and Columbia University collaborators have uncovered compelling evidence that amyotrophic lateral sclerosis (ALS) involves an autoimmune component. The study...

Cartography Biosciences secured $67 million in a Series B funding round led by Pfizer Ventures to advance its lead candidate targeting colorectal cancer. The biotech develops bispecific and...

Asabys Partners, a European life sciences investment firm based in Madrid and Barcelona, has integrated Aliath Bioventures, formerly Alta Life Sciences, in a strategic $468 million consolidation....

Researchers at the University of Pennsylvania demonstrated that a single dose of psilocybin, a psychoactive compound found in certain mushrooms, alleviates symptoms of chronic pain and associated...

Japanese pharmaceutical giant Takeda Pharmaceutical announced its strategic decision to discontinue all cell therapy research and seek external partnerships to advance existing clinic-ready cell...